Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2005; 94(01): 231-232
DOI: 10.1055/s-0037-1614317
DOI: 10.1055/s-0037-1614317
Letters to the Editor
Response to rebuttal: Meta-analysis of the relationship of factor V Leiden and intrauterine growth restriction – based on solid evidence?
Further Information
Publication History
Received
25 April 2005
Accepted after revision
24 May 2005
Publication Date:
15 December 2017 (online)
-
References
- 1 Lindqvist PG, Svensson PJ, Dahlbäck B. et al. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss – a possible evolutionary selection mechanism. Thromb Haemost 1998; 79: 69-73.
- 2 Erhardt E, Stankovics J, Molnar D. et al. High prevalence of factor V Leiden mutation in mothers of premature neonates. Biol Neonate 2000; 78: 145-6.
- 3 Lindqvist PG, Svensson PJ, Marsál K. et al. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.
- 4 Infante-Rivard C, Rivard GE, Yotov WV. et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002; 347: 19-25.
- 5 Howley HE, Walker M, Rodger M. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192: 694-708.